Padraig Andrew O'Connor - 12 Feb 2026 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP, Global Operations
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
12 Feb 2026
Net transactions value
-$33,873
Form type
4
Filing time
17 Feb 2026, 19:07:52 UTC
Previous filing
08 Dec 2025
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
O'Connor Padraig Andrew EVP, Global Operations 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH /s/ Susan Thompson, Attorney-in-Fact 17 Feb 2026 0002098740

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +1,058 +27% $0.000000 4,943 12 Feb 2026 Direct F1
transaction BSX Common Stock Tax liability $33,873 -457 -9.2% $74.12 4,486 12 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -1,058 -33% $0.000000 2,116 12 Feb 2026 Common Stock 1,058 Direct F1, F2
transaction BSX Restricted Stock Units Award $0 +5,059 $0.000000 5,059 12 Feb 2026 Common Stock 5,059 Direct F1, F3
transaction BSX Stock Option (Right to Buy) Award $0 +11,939 $0.000000 11,939 12 Feb 2026 Common Stock 11,939 $74.12 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.
F4 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.